The perioperative enhancing factors that might help the postmenopausal women tolerate the spinal implants
Background Data: Osteoporosis is a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration, with a consequent increase in bone fragility. Moreover, it is a condition that is both preventable and treatable if caught in time. Purpose: Evaluation the different peri...
Guardado en:
Autores principales: | Akram Awadalla, Bashar Assar, Yassin Mustafa, Hosnia Ragab |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Egyptian Spine Association
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d2f7194902b34be8a284d3d952711acb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
por: Paula Rackoff
Publicado: (2009) -
The predictive role of monocyte-lymphocyte ratio and plateletlymphocyte ratio in postmenopausal osteoporosis
por: Ibrahim Kale
Publicado: (2021) -
The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil
por: Baccaro LF, et al.
Publicado: (2015) -
Comparison of OSTA, FRAX and BMI for Predicting Postmenopausal Osteoporosis in a Han Population in Beijing: A Cross Sectional Study
por: Fan Z, et al.
Publicado: (2020) -
The interrelationship of bone and cardiovascular remodeling biomarkers and clinical peculiarities of coronary artery disease in postmenopausal women
por: Natalia Serhiivna Mykhailovska, et al.
Publicado: (2020)